Contralateral C7 nerve transfer for severe pediatric brachial plexus injuries: donor site morbidity

Neel D Bhagat1, Jeffrey N Gross2, Joshua M Adkinson2,3

  • 1Indiana University School of Medicine, Indianapolis, IN, USA. nbhagat@iu.edu.

Insights

Cross C7 (CC7) nerve transfer is a safe surgical option for pediatric patients with severe brachial plexus injuries (BPI), offering robust donor axons with minimal donor site morbidity.

Area of Science:

  • Pediatric surgery
  • Neurosurgery
  • Microsurgery

Background:

  • Pediatric brachial plexus injuries (BPI) can severely impair upper extremity function.
  • Pan-plexus injuries (PPI) necessitate donor nerves beyond the brachial plexus for reconstruction.
  • The cross C7 (CC7) nerve transfer is a viable, though debated, surgical technique.

Observation:

  • This study retrospectively reviewed three pediatric patients (<18 years) undergoing CC7 nerve transfer for BPI between 2021-2022.
  • All patients received concomitant additional nerve transfers.
  • Donor site morbidity was assessed post-operatively.

Findings:

  • Minimal and transient sensory deficits were observed in most patients post-CC7 transfer.
  • One patient experienced mild, persistent paresthesia on the donor side.
  • No motor deficits were reported at the donor site.

Implications:

  • CC7 nerve transfer provides a safe and effective method for augmenting donor motor axons in pediatric PPI.
  • This technique offers a valuable reconstructive option for complex brachial plexus injuries in children.
  • Further research can validate long-term outcomes and refine surgical protocols.
Abstract